Product logins

Find logins to all Clarivate products below.


Blog

Over 12,000 experts in 40+ countries, working with more than 45,000 customers globally.

Featured posts

RiskMark: An integrated conflict‑assessment experience for trademark attorneys RiskMark: An integrated conflict‑assessment experience for trademark attorneys
Blog February 17, 2026
RiskMark: An integrated conflict‑assessment experience for trademark attorneys
Evaluating the societal impact of research: Insights from the global community Evaluating the societal impact of research: Insights from the global community
Blog January 29, 2026
Evaluating the societal impact of research: Insights from the global community
chevron_left
chevron_right
Key market access considerations for long-acting and alternative delivery therapies Key market access considerations for long-acting and alternative delivery therapies
Blog February 20, 2026
Key market access considerations for long-acting and alternative delivery therapies
Biopharma Commercialization FDA
The market access “sweet spots” where payers reimburse more convenient therapies The market access “sweet spots” where payers reimburse more convenient therapies
Blog February 19, 2026
The market access “sweet spots” where payers reimburse more convenient therapies
Biopharma Commercialization FDA
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization
Announcing the Clarivate Academic AI Working Group: Join us in shaping the next generation of Academic AI Announcing the Clarivate Academic AI Working Group: Join us in shaping the next generation of Academic AI
Blog February 16, 2026
Announcing the Clarivate Academic AI Working Group: Join us in shaping the next generation of Academic AI
AI Community engagement Government
What healthcare payers reward: adherence versus outcomes What healthcare payers reward: adherence versus outcomes
Blog February 2, 2026
What healthcare payers reward: adherence versus outcomes
Biopharma HMO IDN
Clarivate ‘highly recommended’ across three categories in WTR 1000 for excellence in trademark services Clarivate ‘highly recommended’ across three categories in WTR 1000 for excellence in trademark services
Blog January 30, 2026
Clarivate ‘highly recommended’ across three categories in WTR 1000 for excellence in trademark services
Brand IP Brand Protection CompuMark
Preliminary injunctions at the UPC: Speed, success and strategy Preliminary injunctions at the UPC: Speed, success and strategy
Blog January 27, 2026
Preliminary injunctions at the UPC: Speed, success and strategy
Unitary Patent Unitary Patent Court
Realizing the value of convenience: payer engagement strategies for pharmas Realizing the value of convenience: payer engagement strategies for pharmas
Blog January 21, 2026
Realizing the value of convenience: payer engagement strategies for pharmas
Consulting Resource Center